Triggering Tumor Immunity Through Angiogenesis Targeting

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-07-0880
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Nanotechnology-Mediated Targeting of Tumor Angiogenesis

Vascular Cell
Computer NetworksDevelopmental NeuroscienceNeurologyCell BiologyCommunications
2011English

Targeting the Tumor Microenvironment: Focus on Angiogenesis

Journal of Oncology
Oncology
2012English

Targeting Vascular NADPH Oxidase 1 Blocks Tumor Angiogenesis Through a PPARα Mediated Mechanism

PLoS ONE
Multidisciplinary
2011English

Berberine Suppressed Tumor Growth Through Regulating Fatty Acid Metabolism and Triggering Cell Apoptosis via Targeting FABPs

Evidence-based Complementary and Alternative Medicine
Alternative MedicineComplementary
2020English

Pristimerin, a Triterpenoid, Inhibits Tumor Angiogenesis by Targeting VEGFR2 Activation

Molecules
Organic ChemistryMolecular MedicineAnalytical ChemistryTheoretical ChemistryPharmaceutical ScienceMedicineDrug DiscoveryChemistryPhysical
2012English

MiR-15a/16 Deficiency Enhances Anti-Tumor Immunity of Glioma-Infiltrating CD8+ T Cells Through Targeting mTOR

International Journal of Cancer
Cancer ResearchOncology
2017English

pH-sensitive Oncolytic Adenovirus Hybrid Targeting Acidic Tumor Microenvironment and Angiogenesis

Journal of Controlled Release
Pharmaceutical Science
2015English

A DNA Vaccine Targeting Angiomotin Inhibits Angiogenesis and Suppresses Tumor Growth

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2006English

Dual Targeting of Vascular Endothelial Growth Factor and Bone Morphogenetic Protein-9/10 Impairs Tumor Growth Through Inhibition of Angiogenesis

Cancer Science
Cancer ResearchMedicineOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy